S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

リアルタイムの更新: Bioventus Inc. [BVS]

取引所: NASDAQ Global Select セクター: Healthcare 産業: Medical - Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-07)

Expected move: +/- 0.00%

最終更新日時4 5月 2024 @ 05:00

0.25% $ 3.97

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 05:00):

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally...

Stats
本日の出来高 52 521.00
平均出来高 142 636
時価総額 253.40M
EPS $0 ( 2024-03-12 )
次の収益日 ( $-0.0500 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.58
ATR14 $0.00500 (0.13%)
Insider Trading
Date Person Action Amount type
2024-04-11 Singleton Mark Leonard Sell 4 000 Class A Common Stock
2024-04-11 D'adamio Anthony Sell 3 054 Class A Common Stock
2024-04-11 Church Katrina J Sell 1 325 Class A Common Stock
2024-04-10 Singleton Mark Leonard Sell 13 000 Restricted Stock Units
2024-04-10 Singleton Mark Leonard Buy 13 000 Class A Common Stock
INSIDER POWER
30.51
Last 95 transactions
Buy: 5 126 917 | Sell: 2 825 440

ボリューム 相関

長: 0.11 (neutral)
短: 0.95 (very strong)
Signal:(55.87) Expect same movement, but be aware

Bioventus Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bioventus Inc. 相関 - 通貨/商品

The country flag -0.15
( neutral )
The country flag -0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.05
( neutral )
The country flag 0.03
( neutral )

Bioventus Inc. 財務諸表

Annual 2023
収益: $512.35M
総利益: $319.35M (62.33 %)
EPS: $-2.49
FY 2023
収益: $512.35M
総利益: $319.35M (62.33 %)
EPS: $-2.49
FY 2022
収益: $512.12M
総利益: $331.08M (64.65 %)
EPS: $-3.48
FY 2021
収益: $130.41M
総利益: $87.77M (67.30 %)
EPS: $-0.00966

Financial Reports:

No articles found.

Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。